المؤلفون: Bente Glintborg, Anne Gitte Loft, Asta Linauskas, Kamilla Danebod, Dorte Vendelbo Jensen, Stavros Chrysidis, Salome Kristensen, Johnny Lillelund Raun, Natalia Manilo, Frank Mehnert, Niels Steen Krogh, Ada Colic, Heidi Lausten Munk, Hafsah Nabi, Marlene Andersen, Maren Høgberget Kalisz, Niels Lomborg, Pia Høger Thygesen, Louise Brot Christensen

المصدر: RMD Open, Vol 8, Iss 2 (2022)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://rmdopen.bmj.com/content/8/2/e002560.full; https://doaj.org/toc/2056-5933

URL الوصول: https://doaj.org/article/b4d656f611a1492fa65ae4695339c26b

المؤلفون: Hafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, Anne Gitte Loft, Jens Kristian Pedersen, Søren Andreas Just, Kamilla Danebod, Heidi Lausten Munk, Salome Kristensen, Natalia Manilo, Ada Colic, Asta Linauskas, Pia Høger Thygesen, Louise Brot Christensen, Maren Høgberget Kalisz, Niels Lomborg, Stavros Chrysidis, Johnny Lillelund Raun, Marlene Andersen, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland, Bente Glintborg

المصدر: Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, e002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560

مصطلحات موضوعية: biosimilar pharmaceuticals, Arthritis, Psoriatic, Immunology, arthritis, rheumatoid, arthritis, psoriatic, Infliximab, Arthritis, Rheumatoid, Biosimilar Pharmaceuticals/therapeutic use, Infliximab/therapeutic use, Treatment Outcome, Rheumatology, Arthritis, Rheumatoid/diagnosis, Immunology and Allergy, Humans, Registries, spondylitis, ankylosing, infliximab, Biosimilar Pharmaceuticals, Arthritis, Psoriatic/diagnosis

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcafac3b27cbee58119c12faba1e028
https://vbn.aau.dk/da/publications/1224b0b0-ee61-4f51-a117-2bb3d48fd527